Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

9342-8530 Quebec Inc DGCRF

Healthcare Biotechnology
Diagnocure Inc is a Canada based biotechnology company. It is primarily engaged in the business activity of development and commercialization of products relating to the diagnosis of cancer. The group generates its revenue from research and license agreement. The head office of the company is located in Quebec, Canada.


GREY:DGCRF - Post by User

9342-8530 Quebec Inc
Bullboard Posts
User Avatar Image
(0)
•••
Comment by ready2go1on Nov 01, 2009 11:25pm
399 Views
Post# 16443237

RE: RE: RE: RE: Gen-Probe call

RE: RE: RE: RE: Gen-Probe call

GCC blood test study  has been completed for some time now and they are working hard crunching the #'s. I am not sure how they will release the results; before or after the study is published. Diagnocure has a good idea how the study looks by now and I know they are looking for ways to get the maximum benefit from the test.
     I take part in a Fantasy Football League and there are several Urologists I compete against; on the smack (chat) board there was alot of questions asked about the pca3 test this week. I answered as best as I could but I was shocked by the interest and the amount of knowledge that was out there by these Urologists. Any time they ask me about the stock, I take it as a big positive that they believe in this "holy grail" of prostate markers, enough to start buying shares of CUR. By the way, you don't even have to ask, I got into this specific league because of the two well know Urologists that were already part of the league.

Lets have a good CUR week

Bullboard Posts
Dealroom for high-potential pre-IPO opportunities